<?xml version="1.0" encoding="UTF-8"?><html>
   <div tagx="ui">1745-6215-16-7</div>
   <div tagx="ji">1745-6215</div>
   <head>
      <div tagx="dochead">Study protocol</div>
      <div tagx="bibl">
         <div tagx="title">
            <p>Early exercise after spinal cord injury (‘Switch-On’): study protocol for a randomised
               controlled trial
            </p>
         </div>
         <ul tagx="aug">
            <li tagx="au">
               <span tagx="snm">Galea</span>
               <span tagx="mi">P</span>
               <span tagx="fnm">Mary</span>
               <span tagx="insr"></span>
               <a href="m.galea@unimelb.edu.au">m.galea@unimelb.edu.au</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Dunlop</span>
               <span tagx="mi">A</span>
               <span tagx="fnm">Sarah</span>
               <span tagx="insr"></span>
               <a href="sarah.dunlop@uwa.edu.au">sarah.dunlop@uwa.edu.au</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Marshall</span>
               <span tagx="fnm">Ruth</span>
               <span tagx="insr"></span>
               <a href="Ruth.Marshall@health.sa.gov.au">Ruth.Marshall@health.sa.gov.au</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Clark</span>
               <span tagx="fnm">Jillian</span>
               <span tagx="insr"></span>
               <a href="Jillian.Clark@health.sa.gov.au">Jillian.Clark@health.sa.gov.au</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Churilov</span>
               <span tagx="fnm">Leonid</span>
               <span tagx="insr"></span>
               <a href="leonid.churilov@florey.edu.au">leonid.churilov@florey.edu.au</a>
            </li>
         </ul>
         <ul tagx="insg">
            <li tagx="ins">
               <p>Department of Medicine (Royal Melbourne Hospital), The University of Melbourne, Parkville,
                  VIC 3010, Australia
               </p>
            </li>
            <li tagx="ins">
               <p>School of Animal Biology (M317), The University of Western Australia, Crawley, WA
                  6009, Australia
               </p>
            </li>
            <li tagx="ins">
               <p>South Australian Spinal Cord Injury Service, Hampstead Rehabilitation Centre, 207-255
                  Hampstead Road, Northfield, SA 5085, Australia
               </p>
            </li>
            <li tagx="ins">
               <p>Florey Institute of Neurosciences and Mental Health, Melbourne Brain Centre (Austin
                  Campus), Heidelberg, VIC 3084, Australia
               </p>
            </li>
         </ul>
         <span tagx="source">Trials</span>
         <span tagx="issn">1745-6215</span>
         <span tagx="pubdate">2015</span>
         <span tagx="volume">16</span>
         <span tagx="issue">1</span>
         <span tagx="fpage">7</span>
         <a href="http://www.trialsjournal.com/content/16/1/7">http://www.trialsjournal.com/content/16/1/7</a>
         <div tagx="xrefbib">
            <div tagx="pubidlist">
               <span tagx="pubid">10.1186/1745-6215-16-7</span>
               <span tagx="pubid">25563584</span>
            </div>
         </div>
      </div>
      <div tagx="history">
         <span tagx="rec">
            <div tagx="date">
               <span tagx="day">11</span>
               <span tagx="month">5</span>
               <span tagx="year">2014</span>
            </div>
         </span>
         <span tagx="acc">
            <div tagx="date">
               <span tagx="day">15</span>
               <span tagx="month">12</span>
               <span tagx="year">2014</span>
            </div>
         </span>
         <span tagx="pub">
            <div tagx="date">
               <span tagx="day">7</span>
               <span tagx="month">1</span>
               <span tagx="year">2015</span>
            </div>
         </span>
      </div>
      <div tagx="cpyrt">
         <span tagx="year">2015</span>
         <div tagx="collab">Galea et al.; licensee BioMed Central.</div>
         <div tagx="note">This is an Open Access article distributed under the terms of the Creative Commons
            Attribution License (
            <a href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided
            the original work is properly credited. The Creative Commons Public Domain Dedication
            waiver (
            <a href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated.
         </div>
      </div>
      <ul tagx="kwdg">
         <li tagx="kwd">Spinal cord injury</li>
         <li tagx="kwd">Randomised controlled trial</li>
         <li tagx="kwd">Early exercise</li>
         <li tagx="kwd">FES cycling</li>
         <li tagx="kwd">Passive cycling</li>
         <li tagx="kwd">Muscle atrophy</li>
         <li tagx="kwd">Biomarkers</li>
         <li tagx="kwd">Osteoporosis</li>
         <li tagx="kwd">Neurological function</li>
         <li tagx="kwd">Immune function</li>
         <li tagx="kwd">Quality of life</li>
      </ul>
      <div id="abstract" tag="abstract">
         <div id="">
            <div tagx="st">
               <h2>Abstract</h2>
            </div>
            <div id="">
               <div tagx="st">
                  <h3>Background</h3>
               </div>
               <p>Spinal cord injury (SCI) leads to a profound muscular atrophy, bone loss and bone
                  fragility. While there is evidence that exercising paralysed muscles may lead to reversal
                  of muscle atrophy in the chronic period after SCI, there is little evidence that exercise
                  can prevent muscle changes early after injury. Moreover, whether exercise can prevent
                  bone loss and microarchitectural decay is not clear.
               </p>
            </div>
            <div id="">
               <div tagx="st">
                  <h3>Methods/Design</h3>
               </div>
               <p>A multi-centre, parallel group, assessor-blinded randomised controlled trial will
                  be conducted. Fifty participants with acute spinal cord injury will be recruited from
                  four SCI units in Australia and New Zealand. Participants will be stratified by site
                  and AIS status and randomised to an experimental or control group. Experimental participants
                  will receive a 12-week programme of functional electrical stimulation (FES)-assisted
                  cycling. Control participants will receive a 12-week programme of passive cycling.
                  The primary outcome is muscle cross-sectional area of the thigh and calf measured
                  using magnetic resonance images (MRI) of the leg. Secondary outcomes include serum
                  biomarkers of SCI osteoporosis (sclerostin, P1NP and β-CTX), markers of immune function
                  (IL-6, IL-10, FGF2, INF-γ, TNF-α), neurological function, body composition, depression
                  and quality of life. Leg MRIs will be measured by a single blinded assessor based
                  in Melbourne. Serum samples will be analysed in a central laboratory. All other characteristics
                  will be measured at baseline and 12 weeks by blinded and trained assessors at each
                  site. The first participant was randomised on 27 November 2012.
               </p>
            </div>
            <div id="">
               <div tagx="st">
                  <h3>Discussion</h3>
               </div>
               <p>The results of this trial will determine the relative effectiveness of a 12-week programme
                  of FES-assisted cycling versus passive cycling in preventing muscle atrophy and maintaining
                  skeletal integrity after spinal cord injury.
               </p>
            </div>
            <div id="">
               <div tagx="st">
                  <h3>Trial registration</h3>
               </div>
               <p>
                  <div tagx="a">ACTRN12611001079932</div> (18 October 2011)
               </p>
            </div>
         </div>
      </div>
   </head>
   <div id="">
      <div tagx="st">
         <h2>Background</h2>
      </div>
      <p>Spinal cord injury (SCI) leads to a profound muscular atrophy, bone loss and bone
         fragility 
         <span tagx="abbrgrp">
            <span tagx="abbr">1</span>
            <span tagx="abbr">2</span>
            <span tagx="abbr">3</span>
         </span>. Fractures lead to a marked deterioration in bone quality, and compromise rehabilitation
         and quality of life 
         <span tagx="abbrgrp">
            <span tagx="abbr">4</span>
         </span>.
      </p>
      <p>Furthermore, recent advances have identified mechanisms that link muscle and bone
         metabolism, thereby identifying such tissues as endocrine organs 
         <span tagx="abbrgrp">
            <span tagx="abbr">5</span>
            <span tagx="abbr">6</span>
         </span>. The discovery that muscle-secreted factors contribute to osteocyte viability 
         <span tagx="abbrgrp">
            <span tagx="abbr">7</span>
         </span> suggests a link between disuse and endocrine functions of bone and between muscle
         endocrine action and susceptibility for chronic disease 
         <span tagx="abbrgrp">
            <span tagx="abbr">8</span>
            <span tagx="abbr">9</span>
         </span>. Such developments have highlighted inter-relationships between the aetiologies of
         sarcopenia and osteopenia 
         <span tagx="abbrgrp">
            <span tagx="abbr">10</span>
         </span>, cardinal features of secondary disuse disorder such as occurs after SCI 
         <span tagx="abbrgrp">
            <span tagx="abbr">11</span>
            <span tagx="abbr">12</span>
         </span>. Recognition that SCI involves an ‘endocrine syndrome’ 
         <span tagx="abbrgrp">
            <span tagx="abbr">13</span>
            <span tagx="abbr">14</span>
         </span> has advanced our understanding of regulatory mechanisms that contribute to the clinical
         features of this catastrophic injury. Given that muscle-secreted factors (myokines)
         have endocrine and other actions, the role of skeletal muscle contraction induced
         by exercise following SCI warrants closer attention.
      </p>
      <p>Thigh girth reduces by 50% within 3 weeks of SCI 
         <span tagx="abbrgrp">
            <span tagx="abbr">15</span>
         </span>; thickness of muscle bulk, measured using ultrasound, reduces by 40% in the first
         month 
         <span tagx="abbrgrp">
            <span tagx="abbr">16</span>
         </span>. A magnetic resonance imaging (MRI) study of changes in muscle cross-sectional area
         (CSA) over the first few months after SCI showed that the mean CSA of the quadriceps,
         hamstring and adductor muscle groups declined by 16%, 14% and 16% respectively 
         <span tagx="abbrgrp">
            <span tagx="abbr">17</span>
         </span>.
      </p>
      <p>Muscle is a dynamic tissue capable of adapting its morphology depending on the functional
         demands placed on it. There is evidence that exercising paralysed muscles through
         functional electrical stimulation (FES)-assisted cycling leads to reversal of atrophy
         
         <span tagx="abbrgrp">
            <span tagx="abbr">18</span>
         </span>. Furthermore, in rats with spinal transection, passive exercise in the form of pedaling
         on a motor-driven cycle results in activation of muscle satellite cells and reversal
         of hindlimb muscle atrophy. This effect is more marked in muscles with slow oxidative
         fibres such as soleus 
         <span tagx="abbrgrp">
            <span tagx="abbr">19</span>
         </span>.
      </p>
      <p>It is still unknown whether unloading of the bones in the paralysed extremities is
         the only factor causing rapid bone loss below the level of injury, or if other factors
         such as neuronal, humoral and vascular adaptations after a SCI are also involved 
         <span tagx="abbrgrp">
            <span tagx="abbr">20</span>
            <span tagx="abbr">21</span>
         </span>. Muscle forces create the peak forces acting on bone, a relationship summarised by
         the mechanostat theory 
         <span tagx="abbrgrp">
            <span tagx="abbr">22</span>
         </span>, which predicts that bone mass, strength and size will respond to increasing muscle
         maximal forces during bone growth, or the loading of mature bone. Unloading through
         disuse or immobilisation will have a negative effect on bone mass and strength, both
         through muscle atrophy and local regulators of cell phenotype, within the bone tissue
         microenvironment.
      </p>
      <p>Sclerostin, encoded by the 
         <i>sost</i> gene, is a Wingless-Int (Wnt) signalling pathway antagonist secreted by osteocytes
         and is a potent inhibitor of bone formation 
         <span tagx="abbrgrp">
            <span tagx="abbr">23</span>
         </span>. Compared to other bone-related proteins, sclerostin is considered a candidate biomarker
         for SCI-induced osteoporosis 
         <span tagx="abbrgrp">
            <span tagx="abbr">24</span>
         </span>. Sclerostin is increased by unloading and suppressed by loading, a feature observed
         at least in the first few years after SCI 
         <span tagx="abbrgrp">
            <span tagx="abbr">25</span>
            <span tagx="abbr">26</span>
         </span>. In addition to the mechanical loading of bone through muscle contraction, muscle
         myokines released from contracting muscles may protect osteocytes from undergoing
         cell death 
         <span tagx="abbrgrp">
            <span tagx="abbr">27</span>
         </span>.
      </p>
      <p>One study has used FES early after injury to 
         <i>prevent</i> muscle changes rather than 
         <i>reverse</i> them when losses are well advanced. Baldi 
         <i>et al</i>. 
         <span tagx="abbrgrp">
            <span tagx="abbr">12</span>
         </span> compared FES-assisted cycling with FES-induced isometric muscle contractions commencing
         within the first 12 to 15 weeks of injury. Control subjects who had had no exercise
         lost 21 to 27% of muscle mass. FES-cycling, but not FES-induced isometric exercise,
         prevented loss of lower limb lean body mass and gluteal lean body mass at both 3 and
         6 months.
      </p>
      <p>Whether exercise can 
         <i>prevent</i> bone loss and microarchitectural decay or reverse it when established is not clear.
         A regimen of FES-assisted isotonic contractions instituted early after SCI did not
         lead to an osteogenic effect in the lower limbs, measured using dual energy X-ray
         absorptiometry 
         <span tagx="abbrgrp">
            <span tagx="abbr">28</span>
         </span>. A 2010 systematic review 
         <span tagx="abbrgrp">
            <span tagx="abbr">29</span>
         </span> has concluded that FES-cycling does not improve or maintain bone at the tibial diaphysis
         in the acute phase, but may increase/maintain lower extremity bone mineral density
         (BMD) in the chronic phase after SCI 
         <span tagx="abbrgrp">
            <span tagx="abbr">30</span>
         </span>, the implication being that site-specific bone adaptation is both time- and dose-dependent
         and thus, mechanisms of bone adaptation may differ in acute and in established SCI.
      </p>
      <p>In this trial, we will provide an exercise programme that involves FES-cycling against
         increasing loads as early as practicable after SCI, commencing when the individual
         is still confined to bed. We hypothesise that muscle activation will prevent muscle
         atrophy. In addition, we hypothesise that mechanical strains associated with loading
         and changing leg position during cycling will inhibit sclerostin levels and thereby
         preserve skeletal structure by reducing inhibition of bone formation and reduce increased
         bone resorption at the cellular level seen early after injury.
      </p>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Methods</h2>
      </div>
      <p>The trial was registered on the Australian and New Zealand Clinical Trials Registry
         (ACTRN12611001079932) on 18 October 2011. The first participant was randomised on
         27 November 2012, and the final participant on 31 March 2014.
      </p>
      <div id="">
         <div tagx="st">
            <h3>Funding</h3>
         </div>
         <p>The study is being funded by the Transport Accident Commission (Victorian Neurotrauma
            Initiative), and the National Health and Medical Research Council of Australia. At
            the conclusion of the trial, all equipment purchased for the trial will be gifted
            to the participating hospitals.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Design</h3>
         </div>
         <p>A multi-centre, assessor-blinded, randomised controlled trial will be conducted. Experimental
            group participants will undertake an intensive 12-week programme of FES-assisted cycling,
            while control group participants will undertake a passive cycling programme over the
            same period. The trial will be conducted in four spinal units in Australia and New
            Zealand. Ethical approval has been obtained from the Human Research Ethics Committees
            at Austin Health in Melbourne (H2012/04476), Royal Perth Hospital in Perth (EC 2012/080),
            Princess Alexandra Hospital in Brisbane (HREC/12/QPAH/085) and the Multi-region Ethics
            Committee in New Zealand (MEC/12/02/020) and at the University of Melbourne (Trial
            Sponsor, HREC 1237599). Participants will be provided with information sheets and
            written informed consent will be obtained prior to recruitment and baseline assessment.
            See Table 
            <span tagx="tblr">1</span> for the schedule of enrolment, interventions, and assessments.
         </p>
         <table>
            <div tagx="title">
               <p>Table 1</p>
            </div>
            <caption>
               <p>
                  <b>Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) checklist:
                     schedule of enrolment, interventions, and assessments
                  </b>
               </p>
            </caption>
            <tgroup>
               <colspec></colspec>
               <colspec></colspec>
               <colspec></colspec>
               <colspec></colspec>
               <colspec></colspec>
               <thead>
                  <tr>
                     <td></td>
                     <td>
                        <p>
                           <b>Enrolment</b>
                        </p>
                     </td>
                     <td>
                        <p>
                           <b>Allocation</b>
                        </p>
                     </td>
                     <td>
                        <p>
                           <b>Intervention</b>
                        </p>
                     </td>
                     <td>
                        <p>
                           <b>Post-intervention</b>
                        </p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>
                           <b>TIMEPOINT</b>
                        </p>
                     </td>
                     <td>
                        <p>
                           <b>
                              <i>-t</i>
                           </b>
                           <sub>
                              <b>
                                 <i>1</i>
                              </b>
                           </sub>
                        </p>
                     </td>
                     <td>
                        <p>
                           <b>0</b>
                        </p>
                     </td>
                     <td>
                        <p>
                           <b>12 weeks</b>
                        </p>
                     </td>
                     <td>
                        <p>
                           <b>12 weeks</b>
                        </p>
                     </td>
                  </tr>
               </thead>
               <div tagx="tfoot">
                  <p>*1-week window allowed for assessments.</p>
                  <p>FES = functional electrical stimulation; ISNCSCI = International Standard for Neurological
                     Classification of Spinal Cord Injury; HADS = Hospital Anxiety and Depression Scale;
                     HUI3 = Health Utilities Index Mark 3; AQoL = Assessment of Quality of Life; WHOQoL-Bref = WHO
                     Quality of Life-Bref.
                  </p>
               </div>
               <tbody>
                  <tr>
                     <td>
                        <p>
                           <b>ENROLMENT:</b>
                        </p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>
                           <b>Eligibility screen</b>
                        </p>
                     </td>
                     <td>
                        <p>X</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>
                           <b>Informed consent</b>
                        </p>
                     </td>
                     <td>
                        <p>X</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>
                           <b>Medical clearance</b>
                        </p>
                     </td>
                     <td>
                        <p>X</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>
                           <b>Allocation</b>
                        </p>
                     </td>
                     <td></td>
                     <td>
                        <p>X</p>
                     </td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>
                           <b>INTERVENTIONS:</b>
                        </p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>
                           <b>
                              <i>FES-assisted cycling</i>
                           </b>
                        </p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>
                           <b>
                              <i>Passive cycling</i>
                           </b>
                        </p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>
                           <b>ASSESSMENTS*:</b>
                        </p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>
                           <b>
                              <i>Muscle cross-sectional area of thigh and calf (1° outcome measure)</i>
                           </b>
                        </p>
                     </td>
                     <td>
                        <p>X</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td>
                        <p>X</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>
                           <b>
                              <i>Serum sclerostin</i>
                           </b>
                        </p>
                     </td>
                     <td>
                        <p>X</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td>
                        <p>X</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>
                           <b>
                              <i>Other serum biomarkers</i>
                           </b>
                        </p>
                     </td>
                     <td>
                        <p>X</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td>
                        <p>X</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>
                           <b>
                              <i>Muscle mass</i>
                           </b>
                        </p>
                     </td>
                     <td>
                        <p>X</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td>
                        <p>X</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>
                           <b>
                              <i>ISNCSCI Motor and Sensory Scores</i>
                           </b>
                        </p>
                     </td>
                     <td>
                        <p>X</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td>
                        <p>X</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>
                           <b>
                              <i>Depression (HADS)</i>
                           </b>
                        </p>
                     </td>
                     <td>
                        <p>X</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td>
                        <p>X</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>
                           <b>
                              <i>Quality of Life</i>
                           </b>
                        </p>
                     </td>
                     <td>
                        <p>X</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td>
                        <p>X</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>
                           <b>
                              <i>(HUI3, AQoL, WHOQoL-Bref)</i>
                           </b>
                        </p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
               </tbody>
            </tgroup>
         </table>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Participants</h3>
         </div>
         <p>Fifty participants with new acute SCI admitted to one of the four trial sites will
            be recruited.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Inclusion criteria</h3>
         </div>
         <p>Participants will be included if they:</p>
         <p>1. Have sustained a complete or incomplete SCI above T12 no more than 3 weeks previously</p>
         <p>2. Have undergone internal fixation of their spinal fracture or whose fracture is
            considered sufficiently stable
         </p>
         <p>3. Are medically stable</p>
         <p>4. Are able to provide informed consent</p>
         <p>5. Have medical and surgical clearance to participate in the study</p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Exclusion criteria</h3>
         </div>
         <p>1. Under 18 years of age</p>
         <p>2. American Spinal Injury Association Impairment Scale (AIS) D (50% of the muscles
            below the injury level are scored as 3 or above) at baseline
         </p>
         <p>3. In halo or other traction</p>
         <p>4. In the ICU</p>
         <p>5. Pressure ulcers</p>
         <p>6. Peripheral nerve lesion</p>
         <p>7. Long bone or pelvic fracture</p>
         <p>8. Lower limb amputation</p>
         <p>9. Metabolic bone disease, including lytic or renal bone disease, or senile osteoporosis</p>
         <p>10. Exposure to drugs that affect bone metabolism (amino-bisphosphonate, high-dose
            glucocorticoids, cyclosporine, anti-epileptic drugs (AEDs))
         </p>
         <p>11. Known contraindications to FES (cardiac pacemaker, epilepsy, pregnancy)</p>
         <p>12. Any other contraindications to participating in exercise programmes, or outcome
            assessments, as advised by the treating physician
         </p>
         <p>13. English language competency insufficient to understand research procedures and
            provide informed consent.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Randomisation</h3>
         </div>
         <p>Participants will be randomly assigned to either the experimental or control group
            with a 1:1 allocation as per a computer-generated randomisation schedule stratified
            by participating site and injury status (AIS) A/B or AIS C). The randomisation schedule
            will be under the control of a central randomisation unit, independent of the trial,
            located at Neuroscience Trials Australia in Melbourne. A participant will be considered
            to have entered the trial once his/her randomisation is revealed to the site coordinator.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Intervention</h3>
         </div>
         <p>All participants will attend the assigned exercise programme for 48 sessions over
            12 weeks, with an intended frequency of 4 times weekly.
         </p>
         <div id="">
            <div tagx="st">
               <h4>Experimental group</h4>
            </div>
            <p>Participants in the experimental group will receive FES-assisted cycling using a Hasomed
               RehaStim FES Unit attached to a MOTOmed cycle (Hasomed GmbH, Magdeburg, Germany) while
               they are confined to bed, and an RT300 cycle (Restorative Therapies, Baltimore, MD,
               USA) when they are able to sit in a chair. Surface electrodes will be applied over
               the belly of the quadriceps, gluteal, and hamstrings muscles according to a standardised
               protocol 
               <span tagx="abbrgrp">
                  <span tagx="abbr">31</span>
               </span>. The pedal cadence will be set to 15 to 50 rev.min
               <sup>−1</sup> Stimulation intensity will be gradually increased to a maximum of 140 mA with a pulse
               width of 0.3 ms at a frequency of 35 Hz 
               <span tagx="abbrgrp">
                  <span tagx="abbr">31</span>
                  <span tagx="abbr">32</span>
               </span>. Participants will exercise at the maximal power output possible at their level of
               recovery. Therapists will evaluate the degree of muscle contraction, power output
               and fatigue, and adjust settings appropriately to maximise time, intensity, and power
               of training with a principle of overloading the muscle. When fatigue occurs, cycling
               can be stopped and then re-commenced after a 5-minute break if muscle contraction
               can be re-elicited. For participants with some degree of volitional muscle activity,
               the settings will be adjusted to ensure that resistance is maintained.
            </p>
            <p>Participants will undertake 30 minutes of cycling on 4 days/week for 12 weeks, initially
               in intermittent periods of exercise with rest breaks, but progressing to a maximum
               of 60 minutes as deemed appropriate by the supervising therapist/assistant. This can
               be undertaken as a single session or split into two sessions, depending on the participant’s
               performance and the availability of staff. All aspects of each training session will
               be recorded.
            </p>
         </div>
         <div id="">
            <div tagx="st">
               <h4>Comparator group</h4>
            </div>
            <p>Participants allocated to this group will undertake up to 60 minutes passive cycling
               on 4 days/week for 12 weeks at identical pedal cadence to the Experimental Group.
               Similar to the Experimental Group, cycling while the participant is confined to bed
               will be with the MOTOmed Letto device (Hasomed GmbH, Magdeburg, Germany) and, once
               mobilised into a wheelchair, may use the RT300 cycle (Restorative Therapies, Baltimore,
               MD, USA) but without FES-evoked contractions.
            </p>
         </div>
         <div id="">
            <div tagx="st">
               <h4>Follow-up period</h4>
            </div>
            <p>All participants will complete a post-intervention visit at the end of the 12-week
               intervention period. Assessments completed at baseline will be repeated. A follow-up
               phone call will be made 1 month after this visit to check on progress or adverse events
               in the intervening period.
            </p>
         </div>
         <div id="">
            <div tagx="st">
               <h4>Quality assurance</h4>
            </div>
            <p>To ensure that treatments are of a high standard and delivered in accordance with
               the trial protocol, therapists responsible for administration of the exercise programmes
               will attend workshops where they will be trained in the delivery of the treatment
               programme and in assessment procedures. Therapists will also be provided with a written
               protocol and standardised case report forms for documentation of assessments and interventions.
            </p>
         </div>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Assessments</h3>
         </div>
         <p>Assessments will occur at baseline, and at 12 weeks after the commencement of the
            intervention. All assessments will be undertaken by therapists blinded to group allocation.
            Any inadvertent unblinding of assessors will be reported.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Primary outcome</h3>
         </div>
         <div id="">
            <div tagx="st">
               <h4>The primary outcome measure is muscle cross-sectional area of the thigh and calf at
                  12 weeks
               </h4>
            </div>
            <p>Magnetic resonance images of the leg and thigh will be collected with a 1.5-Tesla
               magnet. Fifteen transaxial images, 1 cm thick and spaced 0.5 cm apart will be taken
               from the knee joint to the ankle joint (leg) and from the hip joint to the knee joint
               (thigh) using a whole-body coil. Markings on the mid-leg and mid-thigh aligned with
               cross-hairs on the imager will allow for similar positioning during repeat scans.
               The participants’ feet will be strapped to a brace to maintain the ankle joint at
               approximately 90° and the knee and hip joints extended. Participants will wear anti-embolism
               stockings for 30 minutes prior to imaging to minimise fluid shifts in the leg.
            </p>
         </div>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Secondary outcome measures</h3>
         </div>
         <p>To control for sources of pre-analytical variability, participants will be required
            to fast for 8 hours before blood is drawn between 0800 and 0900 hours (35 ml per sample).
            Serum samples will be collected at baseline, 1, 2, 3, 4, 8 and 12 weeks (end of intervention).
            All samples will be separated and stored at ─20°C until assayed in a central laboratory,
            and will be destroyed using standard laboratory techniques after the completion of
            the study.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Serum sclerostin</h3>
         </div>
         <p>Serum sclerostin will be measured using ELISA incorporating a biotinylated antibody/horseradish
            peroxidase-streptavidin for detection of the analyte. The detection limit of the sclerostin
            ELISA is 0.18 
            <i>mg.mL</i>
            <sup>
               <i>−1</i>
            </sup> and the intra-assay coefficient of variability (CV) is between 6 to 10% 
            <span tagx="abbrgrp">
               <span tagx="abbr">33</span>
            </span>.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Other serum markers</h3>
         </div>
         <p>The bone biomarkers N-propeptide of type I procollagen (P1NP) and β-isomerised C-terminal
            telopeptide of collagen type I (β-CTX) will be measured using the electrochemiluminescence
            sandwich immunoassays (both Elecsys 1010 Analytics, Roche Diagnostics, Mannheim, Germany).
         </p>
         <p>The total P1NP assay detects the monomer and trimeric forms of the molecule represented
            in the serum. The reference standards given by the manufacturer for this assay (imprecision
            1.8 to 2.9%) independently were validated (1.4 to 2.3%) (
            <span tagx="abbrgrp">
               <span tagx="abbr">34</span>
            </span>. The inter-assay CVs are 1.4%, 1.7% and 2.0% at 74 μ
            <i>g.L</i>
            <sup>
               <i>−1</i>
            </sup>, 508 μ
            <i>g.L</i>
            <sup>
               <i>−1</i>
            </sup> and 978 μ
            <i>g.L</i>
            <sup>
               <i>−1</i>
            </sup>, and intra-assay CVs are 2.0% and 2.3% at 47 μ
            <i>g.L</i>
            <sup>
               <i>−1</i>
            </sup> and 643 μ
            <i>g.L</i>
            <sup>
               <i>−1</i>
            </sup>
            <span tagx="abbrgrp">
               <span tagx="abbr">34</span>
            </span>.
         </p>
         <p>The monoclonal antibodies used in the Elecysis B-Cross Laps assay recognise all fragments
            of the β-δAA octapeptide of type 1 collagen. Intra-assay precision (CVs) given by
            the manufacturer is 4.6%, 1.8% and 1.0% at 0.08 
            <i>ng.mL</i>
            <sup>
               <i>−1</i>
            </sup>, 0.39 
            <i>ng.mL</i>
            <sup>
               <i>−1</i>
            </sup> and 3.58 
            <i>ng.mL</i>
            <sup>
               <i>−1</i>
            </sup>. Total precision (CV) is 4.7%. 4.3% and 1.6% at 0.08 
            <i>ng.mL</i>
            <sup>
               <i>−1</i>
            </sup>, 0.39 
            <i>ng.mL</i>
            <sup>
               <i>−1</i>
            </sup> and 3.58 
            <i>ng.mL</i>
            <sup>
               <i>−1</i>
            </sup> respectively.
         </p>
         <p>Biomarkers of immune function (systemic low-level inflammation), which also are myokines,
            will be assessed using a MILLIPLEX MAP Human Cytokine/Chemokine Magnetic Bead Panel
            Immunology Multiplex Assay read with a Luminex xMAP® platform (Merck Millipore, Darmstadt,
            Germany) in a magnetic bead format for the determination (
            <i>pg.ml</i>
            <sup>
               <i>−1</i>
            </sup>) of: IL-1β, IL-6, IL-10, IL-15, INF-γ, fibroblast growth factor 2 (FGF2), CX3CL1
            (fractalkine), CCL2 (monocyte chemotactic protein-1: MCP-1), TNF-α, vascular endothelial
            derived growth factor (VEGF) and brain-derived neurotrophic factor (BDNF). Precision
            data given by the manufacturer estimate accuracy as 87 to 107%. Intra-assay and inter-assay
            CVs are given as 2 to 13% and 5 to 19%, respectively.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Muscle mass</h3>
         </div>
         <p>Muscle mass will be determined using standard anthropometric methods (measurement
            of lower limb girths and skinfold thickness) 
            <span tagx="abbrgrp">
               <span tagx="abbr">35</span>
            </span> according to the International Society for the Advancement of Kinanthropometry (ISAK)
            standards. The intraobserver reliability of anthropomentry is high (R &gt; 0.9) 
            <span tagx="abbrgrp">
               <span tagx="abbr">36</span>
            </span>.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>ISNCSCI motor and sensory scores</h3>
         </div>
         <p>Motor and sensory recovery will be measured using the International Standard for Neurological
            Classification of Spinal Cord Injury (ISNCSCI) 
            <span tagx="abbrgrp">
               <span tagx="abbr">37</span>
            </span>. The motor score is derived from testing strength of five key upper limb and five
            key lower limb muscles bilaterally with the subject positioned in the supine position
            (for example, elbow flexors, wrist extensors, hip flexors, quadriceps, dorsiflexors)
            on a scale of 0 = no contraction to 5 = normal resistance through full range of motion.
            Scores are summed to give a total possible score of 50 for the upper extremities and
            50 for the lower extremities. The sensory test involves testing pin-prick and light-touch
            sensation at key points representing each dermatome. Pin-prick and light-touch sensation
            of each dermatome are separately scored on a 3-point scale (0, 1 and 2). Scores will
            be summed to give a total possible score of 224, where a higher score indicates better
            sensation than a lower score. The total ISNCSCI motor, light-touch and pin-prick scores
            are highly reliable when assessed by experienced examiners 
            <span tagx="abbrgrp">
               <span tagx="abbr">38</span>
            </span>.
         </p>
         <p>This assessment will be used during the baseline visit to confirm the participant’s
            motor, sensory and neurological levels as well as the AIS classification, which indicates
            the degree of completeness of the spinal cord lesion prior to randomisation and then
            again at the post-intervention assessment.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Depression</h3>
         </div>
         <p>Depression will be measured using the Hospital Anxiety and Depression Scale (HADS)
            
            <span tagx="abbrgrp">
               <span tagx="abbr">39</span>
            </span>, which has been found to be valid 
            <span tagx="abbrgrp">
               <span tagx="abbr">40</span>
            </span> and reliable 
            <span tagx="abbrgrp">
               <span tagx="abbr">41</span>
            </span> for people with SCI.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Assessment of Quality of Life (AQoL-8)</h3>
         </div>
         <p>The AQoL-8 is a multi-attribute utility instrument. It will be used to evaluate whether
            the study intervention improves participants’ quality of life as well as for an economic
            evaluation of the intervention’s cost-effectiveness. The AQoL-8 is a self-administered
            8-item questionnaire 
            <span tagx="abbrgrp">
               <span tagx="abbr">42</span>
            </span> with excellent test-retest reliability 
            <span tagx="abbrgrp">
               <span tagx="abbr">43</span>
            </span>.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Health Utilities Index Mark 3 (HUI-3)</h3>
         </div>
         <p>HUI-3 is a measure of health-related quality of life widely used in population health
            surveys, clinical studies and cost-utility analyses. HUI-3 includes eight attributes
            (vision, hearing, speech, ambulation, dexterity, emotion, cognition and pain), with
            five or six levels for each attribute. HUI-3 is reliable 
            <span tagx="abbrgrp">
               <span tagx="abbr">44</span>
            </span> and is able to discriminate various aspects of burden associated with chronic conditions
            as well as describing the differences in overall health-related quality of life levels
            
            <span tagx="abbrgrp">
               <span tagx="abbr">45</span>
            </span>.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>WHOQoL-Bref</h3>
         </div>
         <p>The WHOQoL-Bref questionnaire was designed by an international collaboration on quality
            of life by the World Health Organisation. It contains 26 questions about many different
            aspects of quality of life, with some additional questions about the person and his/her
            health. It has good test-retest reliability 
            <span tagx="abbrgrp">
               <span tagx="abbr">46</span>
            </span> and has been found to be a valid measure in people with SCI 
            <span tagx="abbrgrp">
               <span tagx="abbr">47</span>
            </span>.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Statistical analyses</h3>
         </div>
         <div id="">
            <div tagx="st">
               <h4>Sample size</h4>
            </div>
            <p>The power analysis is for a one-way fixed effects analysis of covariance (ANCOVA)
               with two levels that correspond to FES cycling and passive cycling arms of the study.
               This analysis includes baseline value of muscle CSA in the thigh and calf as a covariate,
               and uses the value of muscle CSA in the thigh and calf at week 12 as the primary outcome.
               Based on available pilot data 
               <span tagx="abbrgrp">
                  <span tagx="abbr">17</span>
               </span>, the participants in the passive cycling arm are likely to lose around 33% of the
               baseline muscle CSA (mean = 75, SD = 20) over a period of 12 weeks after SCI (measured
               using MRI). Assuming this loss could be contained to 10% by the proposed FES cycling
               intervention, thus resulting in mean changes of 25 (SD = 20) and 7.5 (SD = 20) for
               passive cycling and FES cycling respectively, the total sample size of 42 patients
               equally distributed between FES cycling and passive cycling arms will yield power
               of 0.8 to reject the null hypothesis at 0.05 level of significance. The ANCOVA is
               conservative (that is assuming no correlation between the baseline and follow-up measures)
               and non-directional (that is two-tailed) which means that an effect in either direction
               will be interpreted. Allowing for a15% drop-out rate, the final sample size for this
               study is calculated to be 50 patients equally distributed between FES cycling and
               passive cycling arms.
            </p>
         </div>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Statistical analysis</h3>
         </div>
         <p>The primary and secondary endpoint analyses will be conducted on an intention-to-treat
            basis. Baseline comparisons between the 2 arms of the study will be made using means
            or medians and proportions with 95% confidence intervals. All endpoints and analyses
            have been prospectively categorised as either primary or secondary. Differences in
            both primary and secondary endpoints between the 2 arms of the study will be tested
            independently at the 0.05 level of significance, using a one-way ANCOVA model that
            will include the baseline value of a given outcome in question as a covariate. No
            formal adjustments will be undertaken to constrain the overall type I error associated
            with the secondary analyses. Their purpose is to supplement evidence from the confirmatory
            primary analysis to help more fully characterise the treatment effect. Results from
            the secondary analyses will be interpreted in this context.
         </p>
         <p>Additional exploratory analyses of the effects of stratification factors on the differences
            in both primary and secondary endpoints between the two arms of the study will be
            undertaken by either explicitly including these factors into the model (injury status)
            or by treating them as random effects in a random-effect regression model (study sites).
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Data integrity and management</h3>
         </div>
         <p>Data will be stored electronically on a database with secured and restricted access.
            Data transfer will be encrypted and any information capable of identifying individuals
            removed.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Withdrawals</h3>
         </div>
         <p>A participant will be considered to have withdrawn from the trial when consent is
            revoked or if the participant cannot be contacted or located. If this occurs, no further
            assessments will be performed. Participants will not be withdrawn from the trial for
            protocol violations.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Monitoring</h3>
         </div>
         <p>The trial will be overseen and monitored by a Programme Manager. The Programme Manager
            will visit each site to examine trial procedures, ensure data quality and monitor
            compliance with the trial protocol. All adverse events and serious adverse events
            will be recorded according to standard procedures. An interim safety analysis is planned
            when 25 participants have completed their post-intervention assessment. It will be
            done by an independent Data Safety Monitoring Board (DSMB) comprising a statistician
            and two rehabilitation doctors. If there are concerns about the safety of participants,
            this board will make a recommendation to the trial steering committee about continuing,
            stopping, or modifying the trial.
         </p>
      </div>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Discussion</h2>
      </div>
      <p>This trial will provide information about the relative effectiveness of FES-assisted
         cycling versus passive cycling in preventing muscle atrophy. This is important because
         muscle atrophy is associated with blood vessel atrophy 
         <span tagx="abbrgrp">
            <span tagx="abbr">48</span>
         </span> and predisposes to the development of pressure ulcers. The mechanisms by which active
         and passive exercise programmes improve function after SCI also need to be better
         understood because they allow for development of new and more effective therapeutic
         strategies. In this study, the control intervention is not standard care but an active
         intervention, involving passive cycling. This ensures that the intensity of both exercise
         programmes is similar, so that the effects of active exercise of the paralysed lower
         limbs can be identified over and above passive movement of the limbs.
      </p>
      <p>This trial will adhere to key methodological principles important for minimising bias
         (International Conference on Harmonisation Good Clinical Practice annotated by the
         Therapeutic Goods Administration of Australia) 
         <span tagx="abbrgrp">
            <span tagx="abbr">49</span>
         </span> and will be reported according to the CONSORT guidelines 
         <span tagx="abbrgrp">
            <span tagx="abbr">50</span>
         </span>. For example, allocation will be concealed and randomised, assessors will be blinded
         and analyses will be performed on an intention-to-treat basis. Therapists and participants
         will not be blinded due to the nature of the intervention. One primary outcome and
         a number of secondary outcomes will be used. The primary outcome is a measure of muscle
         CSA. The secondary outcomes include measures of a biomarker for disuse osteoporosis,
         body composition, neurological function, and quality of life. Importantly, all adverse
         events will be rigorously documented, so that the safety of the interventions can
         be evaluated. It is anticipated that this trial will take 24 months to complete.
      </p>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Trial status</h2>
      </div>
      <p>Recruitment commenced in October 2012. Recruitment continued until 31 May 2014.</p>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Abbreviations</h2>
      </div>
      <p>AED: Anti-epileptic drugs; AIS: American Spinal Injuries Association Impairment Scale;
         ANCOVA: Analysis of covariance; AQoL-8: Assessment of Quality of Life 8; β-CTX: β-isomerised
         C-terminal telopeptide of collagen type I; BDNF: Brain derived neurotrophic factor;
         BMD: Bone mineral density; CCL2: Monocyte chemotactic protein-1(MCP-1); CONSORT: Consolidated
         Standards of Reporting Trials; CSA: Cross-sectional area; CV: Coefficient of variation;
         CX3CL1: Fractalkine; DSMB: Data Safety Monitoring Board; ELISA: Enzyme-linked immunosorbent
         assay; FES: Functional electrical stimulation; FGF2: Fibroblast growth factor 2; HADS:
         Hospital Depression Anxiety Scale; HUI-3: Health Utilities Index Mark 3; IL: Interleukini;
         INF: Interferon; ISAK: International Society for the Advancement of Kinanthropometry;
         ISNCSCI: International Standard for Neurological Classification of Spinal Cord Injury;
         MRI: Magnetic Resonance imaging; P1NP: N-propeptide of type I procollagen; SD: Standard
         deviation; SCI: Spinal cord injury; SPIRIT: Standard Protocol Items: Recommendations
         for Interventional Trials; TNFα: Tumour necrosis factor alpha; VEGF: Vascular endothelial
         derived growth factor; WHOQoL-Bref: World Health Organisation Quality of Life Short
         Form; Wnt: Wingless-related integration site gene.
      </p>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Competing interests</h2>
      </div>
      <p>The authors declare that they have no competing interests.</p>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Authors’ contributions</h2>
      </div>
      <p>MPG, SAD, RM and JC were responsible for the design of the trial, and secured funding.
         MPG is responsible for the co-ordination and management of the trial. LC is responsible
         for statistical design and analysis. All authors have read and approved the final
         manuscript.
      </p>
   </div>
   <div tagx="bm">
      <div tagx="ack">
         <div id="">
            <div tagx="st">
               <h2>Acknowledgements</h2>
            </div>
            <p>Funding from the Transport Accident Commission (Victorian Neurotrauma Initiative)
               and the National Health and Medical Research Council of Australia.
            </p>
         </div>
      </div>
      <div tagx="refgrp">
         <div tagx="bibl">
            <div tagx="title">
               <p>Soft tissue body composition differences in monozygotic twins discordant for spinal
                  cord injury
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Spungen</span>
                  <span tagx="fnm">AM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Wang</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Pierson</span>
                  <span tagx="fnm">RN</span>
                  <div tagx="suf">Jr</div>
               </li>
               <li tagx="au">
                  <span tagx="snm">Bauman</span>
                  <span tagx="fnm">WA</span>
               </li>
            </ul>
            <span tagx="source">J Appl Physiol</span>
            <span tagx="pubdate">2000</span>
            <span tagx="volume">88</span>
            <span tagx="fpage">1310</span>
            <span tagx="lpage">1315</span>
            <div tagx="xrefbib">
               <span tagx="pubid">10749824</span>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Longitudinal study of the bone mineral content and of soft tissue composition after
                  spinal cord section
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Wilmet</span>
                  <span tagx="fnm">E</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ismail</span>
                  <span tagx="fnm">AA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Heilporn</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Welraeds</span>
                  <span tagx="fnm">D</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Bergmann</span>
                  <span tagx="fnm">P</span>
               </li>
            </ul>
            <span tagx="source">Paraplegia</span>
            <span tagx="pubdate">1995</span>
            <span tagx="volume">33</span>
            <span tagx="fpage">674</span>
            <span tagx="lpage">677</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1038/sc.1995.141</span>
                  <span tagx="pubid">8584304</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Continuous loss of bone during chronic immobilization: a monozygotic twin study</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Bauman</span>
                  <span tagx="fnm">WA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Spungen</span>
                  <span tagx="fnm">AM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Wang</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Pierson</span>
                  <span tagx="fnm">RN</span>
                  <div tagx="suf">Jr</div>
               </li>
               <li tagx="au">
                  <span tagx="snm">Schwartz</span>
                  <span tagx="fnm">E</span>
               </li>
            </ul>
            <span tagx="source">Osteoporos Int</span>
            <span tagx="pubdate">1999</span>
            <span tagx="volume">10</span>
            <span tagx="fpage">123</span>
            <span tagx="lpage">127</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1007/s001980050206</span>
                  <span tagx="pubid">10501792</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Lower extremity fractures after spinal cord injury: a retrospective study</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Ragnarsson</span>
                  <span tagx="fnm">KT</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Sell</span>
                  <span tagx="fnm">GH</span>
               </li>
            </ul>
            <span tagx="source">Arch Phys Med Rehabil</span>
            <span tagx="pubdate">1981</span>
            <span tagx="volume">62</span>
            <span tagx="fpage">418</span>
            <span tagx="lpage">423</span>
            <div tagx="xrefbib">
               <span tagx="pubid">7283682</span>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Insulin signalling in osteoblasts integrates bone remodelling and energy metabolism</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Ferron</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Wei</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Yoshizawa</span>
                  <span tagx="fnm">T</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Del Fatto</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">DePinho</span>
                  <span tagx="fnm">RA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Teti</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ducy</span>
                  <span tagx="fnm">P</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Karsenty</span>
                  <span tagx="fnm">G</span>
               </li>
            </ul>
            <span tagx="source">Cell</span>
            <span tagx="pubdate">2010</span>
            <span tagx="volume">142</span>
            <span tagx="fpage">296</span>
            <span tagx="lpage">308</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/j.cell.2010.06.003</span>
                  <span tagx="pubid">2910411</span>
                  <span tagx="pubid">20655470</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Bone-specific insulin resistance disrupts whole-body glucose homeostatis via decreased
                  osteocalcin activation
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Wei</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ferron</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Clarke</span>
                  <span tagx="fnm">CJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hannun</span>
                  <span tagx="fnm">YA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Jiang</span>
                  <span tagx="fnm">H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Blaner</span>
                  <span tagx="fnm">WS</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Karsenty</span>
                  <span tagx="fnm">G</span>
               </li>
            </ul>
            <span tagx="source">J Clin Invest</span>
            <span tagx="pubdate">2014</span>
            <span tagx="volume">124</span>
            <span tagx="fpage">1781</span>
            <span tagx="lpage">1793</span>
            <div tagx="xrefbib">
               <span tagx="pubid">10.1172/JCI72323</span>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>A role for myokines in muscle-bone interactions</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Hamrick</span>
                  <span tagx="fnm">MW</span>
               </li>
            </ul>
            <span tagx="source">Exerc Sport Sci Rev</span>
            <span tagx="pubdate">2011</span>
            <span tagx="volume">39</span>
            <span tagx="fpage">43</span>
            <span tagx="lpage">47</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1097/JES.0b013e318201f601</span>
                  <span tagx="pubid">3791922</span>
                  <span tagx="pubid">21088601</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Muscle as an endocrine organ: focus on muscle-derived interleukin-6</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Pedersen</span>
                  <span tagx="fnm">BK</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Febbraio</span>
                  <span tagx="fnm">MA</span>
               </li>
            </ul>
            <span tagx="source">Physiol Rev</span>
            <span tagx="pubdate">2008</span>
            <span tagx="volume">88</span>
            <span tagx="fpage">1379</span>
            <span tagx="lpage">1406</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1152/physrev.90100.2007</span>
                  <span tagx="pubid">18923185</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Muscles and their myokines</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Pedersen</span>
                  <span tagx="fnm">BK</span>
               </li>
            </ul>
            <span tagx="source">J Exp Biol</span>
            <span tagx="pubdate">2011</span>
            <span tagx="volume">214</span>
            <span tagx="fpage">337</span>
            <span tagx="lpage">346</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1242/jeb.048074</span>
                  <span tagx="pubid">21177953</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Linkage between muscle and bone: common catabolic signals resulting in osteoporosis
                  and sarcopenia
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Kaji</span>
                  <span tagx="fnm">H</span>
               </li>
            </ul>
            <span tagx="source">Curr Opin Clin Nutr Metab Care</span>
            <span tagx="pubdate">2013</span>
            <span tagx="volume">16</span>
            <span tagx="fpage">272</span>
            <span tagx="lpage">277</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1097/MCO.0b013e32835fe6a5</span>
                  <span tagx="pubid">23481148</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Longitudinal study of bone mineral content in the lumbar spine, the forearm and the
                  lower extremities after spinal cord injury
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Biering-Sorensen</span>
                  <span tagx="fnm">F</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Bohr</span>
                  <span tagx="fnm">HH</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Schaadt</span>
                  <span tagx="fnm">OP</span>
               </li>
            </ul>
            <span tagx="source">Eur J Clin Invest</span>
            <span tagx="pubdate">1990</span>
            <span tagx="volume">20</span>
            <span tagx="fpage">330</span>
            <span tagx="lpage">335</span>
            <div tagx="xrefbib">
               <span tagx="pubid">2114994</span>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Muscle atrophy is prevented in patients with acute spinal cord injury using functional
                  electrical stimulation
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Baldi</span>
                  <span tagx="fnm">JC</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Jackson</span>
                  <span tagx="fnm">RD</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Moraille</span>
                  <span tagx="fnm">R</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Mysiw</span>
                  <span tagx="fnm">WJ</span>
               </li>
            </ul>
            <span tagx="source">Spinal Cord</span>
            <span tagx="pubdate">1998</span>
            <span tagx="volume">36</span>
            <span tagx="fpage">463</span>
            <span tagx="lpage">469</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1038/sj.sc.3100679</span>
                  <span tagx="pubid">9670381</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Plasma leptin is directly related to body adiposity in subjects with spinal cord injury</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Bauman</span>
                  <span tagx="fnm">WA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Spungen</span>
                  <span tagx="fnm">AM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Zhong</span>
                  <span tagx="fnm">YG</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Mobbs</span>
                  <span tagx="fnm">CV</span>
               </li>
            </ul>
            <span tagx="source">Horm Metab Res</span>
            <span tagx="pubdate">1996</span>
            <span tagx="volume">28</span>
            <span tagx="fpage">732</span>
            <span tagx="lpage">736</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1055/s-2007-979889</span>
                  <span tagx="pubid">9013753</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Metabolic and endocrine changes in persons aging with spinal cord injury</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Bauman</span>
                  <span tagx="fnm">WA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Spungen</span>
                  <span tagx="fnm">AM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Adkins</span>
                  <span tagx="fnm">RH</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kemp</span>
                  <span tagx="fnm">BJ</span>
               </li>
            </ul>
            <span tagx="source">Assist Technol</span>
            <span tagx="pubdate">1999</span>
            <span tagx="volume">11</span>
            <span tagx="fpage">88</span>
            <span tagx="lpage">96</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1080/10400435.1999.10131993</span>
                  <span tagx="pubid">11010069</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Limb blood flow, cardiac output and quadriceps muscle bulk following spinal cord injury
                  and the effect of training for the Odstock functional electrical stimulation standing
                  system
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Taylor</span>
                  <span tagx="fnm">PN</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ewins</span>
                  <span tagx="fnm">DJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Fox</span>
                  <span tagx="fnm">B</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Grundy</span>
                  <span tagx="fnm">D</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Swain</span>
                  <span tagx="fnm">ID</span>
               </li>
            </ul>
            <span tagx="source">Paraplegia</span>
            <span tagx="pubdate">1993</span>
            <span tagx="volume">31</span>
            <span tagx="fpage">303</span>
            <span tagx="lpage">310</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1038/sc.1993.54</span>
                  <span tagx="pubid">8332376</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Skeletal muscle atrophy and increased intramuscular fat after incomplete spinal cord
                  injury
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Gorgey</span>
                  <span tagx="fnm">AS</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Dudley</span>
                  <span tagx="fnm">GA</span>
               </li>
            </ul>
            <span tagx="source">Spinal Cord</span>
            <span tagx="pubdate">2007</span>
            <span tagx="volume">45</span>
            <span tagx="fpage">304</span>
            <span tagx="lpage">309</span>
            <div tagx="xrefbib">
               <span tagx="pubid">16940987</span>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Influence of complete spinal cord injury on skeletal muscle cross-sectional area within
                  the first 6 months of injury
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Castro</span>
                  <span tagx="fnm">MJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Apple</span>
                  <span tagx="fnm">DF</span>
                  <div tagx="suf">Jr</div>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hillegass</span>
                  <span tagx="fnm">EA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Dudley</span>
                  <span tagx="fnm">GA</span>
               </li>
            </ul>
            <span tagx="source">Eur J Appl Physiol</span>
            <span tagx="pubdate">1999</span>
            <span tagx="volume">80</span>
            <span tagx="fpage">373</span>
            <span tagx="lpage">378</span>
            <div tagx="xrefbib">
               <span tagx="pubid">10.1007/s004210050606</span>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Muscle fiber regeneration in human permanent motoneuron denervation: relevance to
                  safety and effectiveness of FES-training which induces recovery in SCI subjects
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Carraro</span>
                  <span tagx="fnm">U</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Rossini</span>
                  <span tagx="fnm">K</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Mayr</span>
                  <span tagx="fnm">W</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kern</span>
                  <span tagx="fnm">H</span>
               </li>
            </ul>
            <span tagx="source">Artif Organs</span>
            <span tagx="pubdate">2005</span>
            <span tagx="volume">29</span>
            <span tagx="fpage">187</span>
            <span tagx="lpage">191</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1111/j.1525-1594.2005.29032.x</span>
                  <span tagx="pubid">15725214</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Early changes in muscle fiber size and gene expression in response to spinal cord
                  transaction and exercise
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Dupont-Versteegden</span>
                  <span tagx="fnm">EE</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Houlé</span>
                  <span tagx="fnm">JD</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Gurley</span>
                  <span tagx="fnm">CM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Petersen</span>
                  <span tagx="fnm">CA</span>
               </li>
            </ul>
            <span tagx="source">Am J Physiol Cell Physiol</span>
            <span tagx="pubdate">1998</span>
            <span tagx="volume">275</span>
            <span tagx="fpage">1124</span>
            <span tagx="lpage">1133</span>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Rapid vascular adaptations to training and detraining of persons with spinal cord
                  injury
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Thijssen</span>
                  <span tagx="fnm">DH</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ellenkamp</span>
                  <span tagx="fnm">R</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Smits</span>
                  <span tagx="fnm">P</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hopman</span>
                  <span tagx="fnm">MT</span>
               </li>
            </ul>
            <span tagx="source">Arch Phys Med Rehabil</span>
            <span tagx="pubdate">2006</span>
            <span tagx="volume">87</span>
            <span tagx="fpage">474</span>
            <span tagx="lpage">481</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/j.apmr.2005.11.005</span>
                  <span tagx="pubid">16571385</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Early modifications of biochemical markers of bone metabolism in spinal cord injury
                  patients. A preliminary study
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Uebelhart</span>
                  <span tagx="fnm">D</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hartmann</span>
                  <span tagx="fnm">D</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Vuagnat</span>
                  <span tagx="fnm">H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Castanier</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hachen</span>
                  <span tagx="fnm">HJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Chantraine</span>
                  <span tagx="fnm">A</span>
               </li>
            </ul>
            <span tagx="source">Scand J Rehabil Med</span>
            <span tagx="pubdate">1994</span>
            <span tagx="volume">26</span>
            <span tagx="fpage">197</span>
            <span tagx="lpage">202</span>
            <div tagx="xrefbib">
               <span tagx="pubid">7878394</span>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Bone’s mechanostat: a 2003 update</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Frost</span>
                  <span tagx="fnm">HM</span>
               </li>
            </ul>
            <span tagx="source">Anat Rec</span>
            <span tagx="pubdate">2003</span>
            <span tagx="volume">275A</span>
            <span tagx="fpage">1081</span>
            <span tagx="lpage">1101</span>
            <div tagx="xrefbib">
               <span tagx="pubid">10.1002/ar.a.10119</span>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>An overview of the regulation of bone remodellimg at the cellular level</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Kular</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Tickner</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Chim</span>
                  <span tagx="fnm">SM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Xu</span>
                  <span tagx="fnm">J</span>
               </li>
            </ul>
            <span tagx="source">Clin Biochem</span>
            <span tagx="pubdate">2012</span>
            <span tagx="volume">45</span>
            <span tagx="fpage">863</span>
            <span tagx="lpage">873</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/j.clinbiochem.2012.03.021</span>
                  <span tagx="pubid">22465238</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Sclerostin: a candidate biomarker of SCI-induced osteoporosis</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Morse</span>
                  <span tagx="fnm">LR</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Sudhakar</span>
                  <span tagx="fnm">S</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Lazzari</span>
                  <span tagx="fnm">AA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Garschick</span>
                  <span tagx="fnm">W</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Zafonte</span>
                  <span tagx="fnm">R</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Battaglino</span>
                  <span tagx="fnm">RA</span>
               </li>
            </ul>
            <span tagx="source">Osteoporos Int</span>
            <span tagx="pubdate">2013</span>
            <span tagx="volume">24</span>
            <span tagx="fpage">961</span>
            <span tagx="lpage">968</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1007/s00198-012-2072-0</span>
                  <span tagx="pubid">3611240</span>
                  <span tagx="pubid">22801952</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Spinal cord injury-induced osteoporosis: pathogenesis and emerging therapies</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Battaglino</span>
                  <span tagx="fnm">RA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Lazzari</span>
                  <span tagx="fnm">AA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Garshick</span>
                  <span tagx="fnm">E</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Morse</span>
                  <span tagx="fnm">LR</span>
               </li>
            </ul>
            <span tagx="source">Curr Osteopros Rep</span>
            <span tagx="pubdate">2012</span>
            <span tagx="volume">10</span>
            <span tagx="fpage">278</span>
            <span tagx="lpage">285</span>
            <div tagx="xrefbib">
               <span tagx="pubid">10.1007/s11914-012-0117-0</span>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Circulating sclerostin is elevated in short-term and reduced in long-term SCI</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Battaglino</span>
                  <span tagx="fnm">RA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Sudhakar</span>
                  <span tagx="fnm">S</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Lazzari</span>
                  <span tagx="fnm">AA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Garschick</span>
                  <span tagx="fnm">E</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Zafonte</span>
                  <span tagx="fnm">R</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Morse</span>
                  <span tagx="fnm">LR</span>
               </li>
            </ul>
            <span tagx="source">Bone</span>
            <span tagx="pubdate">2012</span>
            <span tagx="volume">51</span>
            <span tagx="fpage">600</span>
            <span tagx="lpage">605</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/j.bone.2012.04.019</span>
                  <span tagx="pubid">3412894</span>
                  <span tagx="pubid">22575440</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Skeletal muscle secreted factors prevent glucocorticoid-induced osteocyte apoptosis
                  through activation of β-catenin
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Jähn</span>
                  <span tagx="fnm">K</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Lara-Castillo</span>
                  <span tagx="fnm">N</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Brotto</span>
                  <span tagx="fnm">L</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Mo</span>
                  <span tagx="fnm">CL</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Johnson</span>
                  <span tagx="fnm">ML</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Brotto</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Bonewald</span>
                  <span tagx="fnm">LF</span>
               </li>
            </ul>
            <span tagx="source">Eur Cells Mater</span>
            <span tagx="pubdate">2012</span>
            <span tagx="volume">24</span>
            <span tagx="fpage">197</span>
            <span tagx="lpage">210</span>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Physiological effects of lower extremity functional electrical stimulation in early
                  spinal cord injury: lack of efficacy to prevent bone loss
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Clark</span>
                  <span tagx="fnm">JM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Jelbart</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Rischbieth</span>
                  <span tagx="fnm">H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Strayer</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Chatterton</span>
                  <span tagx="fnm">B</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Schultz</span>
                  <span tagx="fnm">C</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Marshall</span>
                  <span tagx="fnm">R</span>
               </li>
            </ul>
            <span tagx="source">Spinal Cord</span>
            <span tagx="pubdate">2007</span>
            <span tagx="volume">45</span>
            <span tagx="fpage">78</span>
            <span tagx="lpage">85</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1038/sj.sc.3101929</span>
                  <span tagx="pubid">16636686</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Bone health following spinal cord injury</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Ashe</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Craven</span>
                  <span tagx="fnm">BC</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Krassioukov</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Eng</span>
                  <span tagx="fnm">J</span>
               </li>
            </ul>
            <span tagx="source">Spinal Cord Injury Rehabilitation Evidence</span>
            <div tagx="publisher">Burnaby BC, Canada: Monkey Hill Health Communications</div>
            <div tagx="editor">Burnaby BC, Eng JJ, Teasell RW, Miller WC, Wolfe DL, Townson AF, Hsieh JTC, Connolly
               SJ, Mehta S, Sakakibara BM
            </div>
            <div tagx="series">
               <div tagx="title">
                  <p>Version 3.0</p>
               </div>
            </div>
            <span tagx="pubdate">2010</span>
            <span tagx="fpage">1</span>
            <span tagx="lpage">29</span>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Bone steady-state is established at reduced bone strength after spinal cord injury:
                  a longitudinal study using peripheral quantitative computed tomography (pQCT)
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Frotzler</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Berger</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Knecht</span>
                  <span tagx="fnm">H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Eser</span>
                  <span tagx="fnm">P</span>
               </li>
            </ul>
            <span tagx="source">Bone</span>
            <span tagx="pubdate">2008</span>
            <span tagx="volume">43</span>
            <span tagx="fpage">549</span>
            <span tagx="lpage">555</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/j.bone.2008.05.006</span>
                  <span tagx="pubid">18567554</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Cardiovascular and metabolic responses during functional electric stimulation cycling
                  at different cadences
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Fornusek</span>
                  <span tagx="fnm">C</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Davis</span>
                  <span tagx="fnm">GM</span>
               </li>
            </ul>
            <span tagx="source">Arch Phys Med Rehabil</span>
            <span tagx="pubdate">2008</span>
            <span tagx="volume">89</span>
            <span tagx="fpage">719</span>
            <span tagx="lpage">725</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/j.apmr.2007.09.035</span>
                  <span tagx="pubid">18374003</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Effect of electrical stimulation-induced cycling on bone mineral density in spinal
                  cord injured patients
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Eser</span>
                  <span tagx="fnm">P</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">de Bruin</span>
                  <span tagx="fnm">ED</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Telley</span>
                  <span tagx="fnm">I</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Lechner</span>
                  <span tagx="fnm">HE</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Knecht</span>
                  <span tagx="fnm">H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Stüssi</span>
                  <span tagx="fnm">G</span>
               </li>
            </ul>
            <span tagx="source">Eur J Clin Invest</span>
            <span tagx="pubdate">2003</span>
            <span tagx="volume">33</span>
            <span tagx="fpage">412</span>
            <span tagx="lpage">419</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1046/j.1365-2362.2003.01156.x</span>
                  <span tagx="pubid">12713456</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Increased sclerostin serum levels associated with bone formation and resorption markers
                  in patients with immobilization-induced bone loss
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Gaudio</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Pennisi</span>
                  <span tagx="fnm">P</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Bratengeier</span>
                  <span tagx="fnm">C</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Torrisi</span>
                  <span tagx="fnm">V</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Lindner</span>
                  <span tagx="fnm">B</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Mangiafico</span>
                  <span tagx="fnm">RA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Pulvirenti</span>
                  <span tagx="fnm">I</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hawa</span>
                  <span tagx="fnm">G</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Tringali</span>
                  <span tagx="fnm">G</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Fiore</span>
                  <span tagx="fnm">CE</span>
               </li>
            </ul>
            <span tagx="source">J Clin Endocrinol Metab</span>
            <span tagx="pubdate">2010</span>
            <span tagx="volume">95</span>
            <span tagx="fpage">2248</span>
            <span tagx="lpage">2253</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1210/jc.2010-0067</span>
                  <span tagx="pubid">20305005</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Analytical evaluation of commercial P1NP assay</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Marcius</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Vrkic</span>
                  <span tagx="fnm">N</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Getaldić-Švarc</span>
                  <span tagx="fnm">B</span>
               </li>
            </ul>
            <span tagx="source">Biochemia Medica</span>
            <span tagx="pubdate">2006</span>
            <span tagx="volume">16</span>
            <span tagx="fpage">178</span>
            <span tagx="lpage">190</span>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>An anthropometric determination of leg fat and muscle plus bone volumes in male and
                  female adults
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Jones</span>
                  <span tagx="fnm">PRM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Pearson</span>
                  <span tagx="fnm">J</span>
               </li>
            </ul>
            <span tagx="source">J Physiol</span>
            <span tagx="pubdate">1969</span>
            <span tagx="volume">204</span>
            <span tagx="fpage">63</span>
            <span tagx="lpage">66</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1113/jphysiol.1969.sp008898</span>
                  <span tagx="pubid">1351593</span>
                  <span tagx="pubid">4310944</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Interviewer variability in anthropometric measurements and estimates of body composition</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Klipstein-Grobusch</span>
                  <span tagx="fnm">K</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Georg</span>
                  <span tagx="fnm">T</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Boeing</span>
                  <span tagx="fnm">H</span>
               </li>
            </ul>
            <span tagx="source">Int J Epidemiol</span>
            <span tagx="pubdate">1997</span>
            <span tagx="volume">26</span>
            <span tagx="issue">Suppl 1</span>
            <span tagx="fpage">S174</span>
            <span tagx="lpage">S180</span>
            <div tagx="xrefbib">
               <span tagx="pubid">9126545</span>
            </div>
         </div>
         <div tagx="bibl">
            <ul tagx="aug">
               <li tagx="au">
                  <div tagx="cnm">American Spinal Injury Association</div>
               </li>
            </ul>
            <span tagx="source">Reference Manual of the International Standards for Neurological Classification of
               Spinal Cord Injury
            </span>
            <div tagx="publisher">Chicago, IL: American Spinal Injury Association</div>
            <span tagx="pubdate">2003</span>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Inter-rater reliability of motor and sensory examinations peformed according to American
                  Spinal Injury Association standards
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Savic</span>
                  <span tagx="fnm">G</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Bergström</span>
                  <span tagx="fnm">EMK</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Frankel</span>
                  <span tagx="fnm">HL</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Jamous</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Jones</span>
                  <span tagx="fnm">PW</span>
               </li>
            </ul>
            <span tagx="source">Spinal Cord</span>
            <span tagx="pubdate">2007</span>
            <span tagx="volume">45</span>
            <span tagx="fpage">444</span>
            <span tagx="lpage">451</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1038/sj.sc.3102044</span>
                  <span tagx="pubid">17387316</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>The hospital anxiety and depression scale</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Zigmond</span>
                  <span tagx="fnm">AS</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Snaith</span>
                  <span tagx="fnm">RP</span>
               </li>
            </ul>
            <span tagx="source">Acta Psychiatr Scand</span>
            <span tagx="pubdate">1983</span>
            <span tagx="volume">67</span>
            <span tagx="fpage">361</span>
            <span tagx="lpage">370</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1111/j.1600-0447.1983.tb09716.x</span>
                  <span tagx="pubid">6880820</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>A preliminary psychometric evaluation of the Hospital Anxiety and Depression Scale
                  (HADS) in 963 people living with spinal cord injury
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Woolrich</span>
                  <span tagx="fnm">RA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kennedy</span>
                  <span tagx="fnm">P</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Tasiemski</span>
                  <span tagx="fnm">T</span>
               </li>
            </ul>
            <span tagx="source">Psychol Health Med</span>
            <span tagx="pubdate">2006</span>
            <span tagx="volume">11</span>
            <span tagx="fpage">80</span>
            <span tagx="lpage">90</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1080/13548500500294211</span>
                  <span tagx="pubid">17129897</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Evaluation of the psychometric characteristics of the Spanish version of the Hospital
                  Anxiety and Depression Scale
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Quintana</span>
                  <span tagx="fnm">JM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Padierna</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Esteban</span>
                  <span tagx="fnm">C</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Arostegui</span>
                  <span tagx="fnm">I</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Bilbao</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ruiz</span>
                  <span tagx="fnm">I</span>
               </li>
            </ul>
            <span tagx="source">Acta Psychiatr Scand</span>
            <span tagx="pubdate">2003</span>
            <span tagx="volume">107</span>
            <span tagx="fpage">216</span>
            <span tagx="lpage">221</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1034/j.1600-0447.2003.00062.x</span>
                  <span tagx="pubid">12580829</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Assessing utility where short measures are required: development of the Short Assessment
                  of Quality of Life-8 (AQoL-8) Instrument
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Hawthorne</span>
                  <span tagx="fnm">G</span>
               </li>
            </ul>
            <span tagx="source">Value Health</span>
            <span tagx="pubdate">2009</span>
            <span tagx="volume">12</span>
            <span tagx="fpage">948</span>
            <span tagx="lpage">957</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1111/j.1524-4733.2009.00526.x</span>
                  <span tagx="pubid">19490558</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Richardson</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Iezzi</span>
                  <span tagx="fnm">A</span>
               </li>
            </ul>
            <span tagx="source">Psychometric validity and the AQoL-8D multi attribute utility instrument</span>
            <div tagx="publisher">Melbourne Australia: Centre for Health Economics Monash University</div>
            <span tagx="pubdate">2011</span>
            <span tagx="fpage">13</span>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>A comparison of health utility measures for the evaluation of multiple sclerosis treatments</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Fisk</span>
                  <span tagx="fnm">JD</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Brown</span>
                  <span tagx="fnm">MG</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Sketris</span>
                  <span tagx="fnm">IS</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Metz</span>
                  <span tagx="fnm">LM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Murray</span>
                  <span tagx="fnm">TJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Stadnyk</span>
                  <span tagx="fnm">KJ</span>
               </li>
            </ul>
            <span tagx="source">J Neurol Neurosurg Psychiatr</span>
            <span tagx="pubdate">2005</span>
            <span tagx="volume">76</span>
            <span tagx="fpage">58</span>
            <span tagx="lpage">63</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1136/jnnp.2003.017897</span>
                  <span tagx="pubid">1739294</span>
                  <span tagx="pubid">15607996</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>The Health Utilities Index (HUI): concepts, measurement properties and applications</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Horsman</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Furlong</span>
                  <span tagx="fnm">W</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Feeny</span>
                  <span tagx="fnm">D</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Torrance</span>
                  <span tagx="fnm">G</span>
               </li>
            </ul>
            <span tagx="source">Health Qual Life Outcomes</span>
            <span tagx="pubdate">2003</span>
            <span tagx="volume">1</span>
            <span tagx="fpage">54</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1186/1477-7525-1-54</span>
                  <span tagx="pubid">293474</span>
                  <span tagx="pubid">14613568</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Development of the World Health Organization WHOQOL-BREF quality of life assessment</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Group</span>
                  <span tagx="fnm">WHOQOL</span>
               </li>
            </ul>
            <span tagx="source">Psychol Med</span>
            <span tagx="pubdate">1998</span>
            <span tagx="volume">28</span>
            <span tagx="fpage">551</span>
            <span tagx="lpage">558</span>
            <div tagx="xrefbib">
               <span tagx="pubid">9626712</span>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>A validity study of the WHOQOLBREF assessment in persons with traumatic spinal cord
                  injury
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Jang</span>
                  <span tagx="fnm">Y</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hsieh</span>
                  <span tagx="fnm">C-L</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Wang</span>
                  <span tagx="fnm">Y-H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Wu</span>
                  <span tagx="fnm">Y-H</span>
               </li>
            </ul>
            <span tagx="source">Arch Phys Med Rehabil</span>
            <span tagx="pubdate">2004</span>
            <span tagx="volume">85</span>
            <span tagx="fpage">1890</span>
            <span tagx="lpage">1895</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/j.apmr.2004.02.032</span>
                  <span tagx="pubid">15520987</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Rapid and extensive arterial adaptations after spinal cord injury</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">De Groot</span>
                  <span tagx="fnm">P</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Bleeker</span>
                  <span tagx="fnm">MW</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">van Kuppevelt</span>
                  <span tagx="fnm">DH</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">van der Woude</span>
                  <span tagx="fnm">LH</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hopman</span>
                  <span tagx="fnm">MT</span>
               </li>
            </ul>
            <span tagx="source">Arch Phys Med Rehabil</span>
            <span tagx="pubdate">2006</span>
            <span tagx="volume">87</span>
            <span tagx="fpage">688</span>
            <span tagx="lpage">696</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/j.apmr.2006.01.022</span>
                  <span tagx="pubid">16635632</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <ul tagx="aug">
               <li tagx="au">
                  <div tagx="cnm">Therapeutic Good Administration</div>
               </li>
            </ul>
            <span tagx="source">Note for guidance on good clinical practice (CPMP/ICH/135/95) annotated with TGA comments</span>
            <div tagx="publisher">Canberra Australia: Commonwealth Department of Health and Aged Care</div>
            <span tagx="pubdate">2000</span>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel
                  group randomised trials
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Moher</span>
                  <span tagx="fnm">D</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hopewell</span>
                  <span tagx="fnm">S</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Schulz</span>
                  <span tagx="fnm">KF</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Montori</span>
                  <span tagx="fnm">V</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Gøtzsche</span>
                  <span tagx="fnm">PC</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Devereaux</span>
                  <span tagx="fnm">PJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Elbourne</span>
                  <span tagx="fnm">D</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Egger</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Altman</span>
                  <span tagx="fnm">DG</span>
               </li>
            </ul>
            <span tagx="source">BMJ</span>
            <span tagx="pubdate">2010</span>
            <span tagx="volume">340</span>
            <span tagx="fpage">c869</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1136/bmj.c869</span>
                  <span tagx="pubid">2844943</span>
                  <span tagx="pubid">20332511</span>
               </div>
            </div>
         </div>
      </div>
   </div>
</html>